Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125528971 | 12552897 | 1 | I | 201604 | 20160705 | 20160713 | 20160713 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201607001252 | ELI LILLY AND CO | 72.63 | YR | F | Y | 83.00000 | KG | 20160713 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125528971 | 12552897 | 1 | PS | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK UNK, WEEKLY (1/W) | U | 20509 | /wk | ||||||||
| 125528971 | 12552897 | 2 | C | HALAVEN | ERIBULIN MESYLATE | 1 | Unknown | UNK, WEEKLY (1/W) | 0 | /wk | |||||||||
| 125528971 | 12552897 | 3 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 160 MG, QD | 0 | 160 | MG | QD | ||||||||
| 125528971 | 12552897 | 4 | C | VALSARTAN. | VALSARTAN | 1 | 160 MG, UNK | 0 | 160 | MG | |||||||||
| 125528971 | 12552897 | 5 | C | CICLETANINE | CICLETANINE | 1 | 50 MG, QD | 0 | 50 | MG | QD | ||||||||
| 125528971 | 12552897 | 6 | C | RILMENIDINE | RILMENIDINE | 1 | 1 MG, QD | 0 | 1 | MG | QD | ||||||||
| 125528971 | 12552897 | 7 | C | HUMALOG | INSULIN LISPRO | 1 | 26 IU, BID | 0 | 26 | IU | BID | ||||||||
| 125528971 | 12552897 | 8 | C | HUMALOG | INSULIN LISPRO | 1 | 26 IU, EACH MORNING | 0 | 26 | IU | QD | ||||||||
| 125528971 | 12552897 | 9 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | 1.5 DF, EACH MORNING | 0 | 1.5 | DF | QD | ||||||||
| 125528971 | 12552897 | 10 | C | MOPRAL /00661201/ | OMEPRAZOLE SODIUM | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 125528971 | 12552897 | 11 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 500 MG, PRN | 0 | 500 | MG | |||||||||
| 125528971 | 12552897 | 12 | C | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | 25 MG, EACH EVENING | 0 | 25 | MG | QD | ||||||||
| 125528971 | 12552897 | 13 | C | STILNOX | ZOLPIDEM TARTRATE | 1 | UNK, PRN | 0 | |||||||||||
| 125528971 | 12552897 | 14 | C | DUROGESIC | FENTANYL | 1 | 25 UG, EVERY HOUR | 0 | 25 | UG | /hr |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125528971 | 12552897 | 1 | Lymphangiosis carcinomatosa |
| 125528971 | 12552897 | 2 | Lymphangiosis carcinomatosa |
| 125528971 | 12552897 | 3 | Product used for unknown indication |
| 125528971 | 12552897 | 4 | Product used for unknown indication |
| 125528971 | 12552897 | 5 | Product used for unknown indication |
| 125528971 | 12552897 | 6 | Product used for unknown indication |
| 125528971 | 12552897 | 7 | Product used for unknown indication |
| 125528971 | 12552897 | 9 | Product used for unknown indication |
| 125528971 | 12552897 | 10 | Product used for unknown indication |
| 125528971 | 12552897 | 11 | Product used for unknown indication |
| 125528971 | 12552897 | 12 | Product used for unknown indication |
| 125528971 | 12552897 | 13 | Product used for unknown indication |
| 125528971 | 12552897 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125528971 | 12552897 | OT |
| 125528971 | 12552897 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125528971 | 12552897 | Blood potassium decreased | |
| 125528971 | 12552897 | Gamma-glutamyltransferase increased | |
| 125528971 | 12552897 | Haemoglobin decreased | |
| 125528971 | 12552897 | Malignant neoplasm progression | |
| 125528971 | 12552897 | Neutrophil count decreased | |
| 125528971 | 12552897 | Pruritus | |
| 125528971 | 12552897 | Rash maculo-papular | |
| 125528971 | 12552897 | Transaminases increased | |
| 125528971 | 12552897 | Urinary tract infection | |
| 125528971 | 12552897 | Viral pharyngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125528971 | 12552897 | 1 | 20160331 | 20160530 | 0 |